Tom Anderson

Track

Insider profile

Positions

Position Company Period
Chief Commercial Strategy Officer SAGE Therapeutics Inc April 1, 2014 - Dec. 31, 2017
Tom Anderson's trades of SAGE Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
119.81
Quantity 57,883 -0.4%
Value US$1,085,725
Transaction date
Planned sale
Price
385.16
Quantity 74,795 +20.8%
Value US$4,980,343
Transaction date
Planned sale
Price
393.63
Quantity 22,390 +5.1%
Value US$2,832,941
Transaction date
Purchase
Price
18.00
Quantity 6,000 +inf%
Value US$108,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2016-11-28 2016-11-15
PlS Planned sale
57,883 -0.4%
119.81
US$1,085,725 		57,883 -0.4% 119.81 US$1,085,725
2015-08-11 2015-08-10
PlS Planned sale
74,795 +20.8%
385.16
US$4,980,343 		74,795 +20.8% 385.16 US$4,980,343
2015-08-11 2015-08-10
PlS Planned sale
22,390 +5.1%
393.63
US$2,832,941 		22,390 +5.1% 393.63 US$2,832,941
2015-06-08 2015-06-08
PlS Planned sale
1,200 -16.7%
78.56
US$94,272 		1,200 -16.7% 78.56 US$94,272
2015-06-08 2015-06-08
PlS Planned sale
4,300 -37.4%
79.95
US$343,785 		4,300 -37.4% 79.95 US$343,785
2014-07-23 2014-07-23
B Purchase
6,000 +inf%
18.00
US$108,000 		6,000 +inf% 18.00 US$108,000